Revenue: The sum of all revenue fields included for a company's operating activities.
Cytokinetics, Incorporated (CYTK) had Revenue of $1.58M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$1.58M |
$-161.38M |
|
-- |
|
$1.58M |
|
$157.21M |
|
$-155.63M |
|
$-5.75M |
|
$-161.38M |
|
$-161.38M |
|
$-161.38M |
|
$-161.38M |
|
$-161.38M |
|
$-161.38M |
|
$-155.63M |
|
$-153.33M |
|
118.50M |
|
118.50M |
|
$-1.36 |
|
$-1.36 |
|
| Balance Sheet Financials | |
$956.05M |
|
$67.17M |
|
$308.00M |
|
$1.26B |
|
$159.73M |
|
$645.17M |
|
$1.37B |
|
$1.53B |
|
$-266.41M |
|
$-266.41M |
|
$-266.41M |
|
119.22M |
|
| Cash Flow Statement Financials | |
$-131.62M |
|
$105.96M |
|
$4.75M |
|
$95.23M |
|
$74.06M |
|
$-21.18M |
|
$23.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.99 |
|
-- |
|
-- |
|
1.70 |
|
-2.47 |
|
100.00% |
|
-9856.30% |
|
-9856.30% |
|
-- |
|
-10220.14% |
|
-10220.14% |
|
$-137.28M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.78 |
|
114.68 |
|
60.57% |
|
60.57% |
|
-12.77% |
|
-42.61% |
|
$-2.23 |
|
$-1.16 |
|
$-1.11 |
|